Dr. Sakshi Jasra, MD

Dr. Jasra practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Jasra's NPI, 1578991675, was assigned on October 29, 2013. Dr. Jasra holds Vermont license 042-0014373.

Dr. Jasra's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Jasra's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Jasra is also affiliated with Champlain Valley Physicians Hospital. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Jasra to 2 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jasra practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jasra's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jasra is licensed in Vermont.

CMS data shows 414 Medicare services from Dr. Jasra across 7 procedure codes in 2024, for 173 Medicare patients. Medicare paid $36,979 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Jasra in 2024. The largest group is 65 to 74, with 72 patients. 70% of them have high blood pressure, and 69% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jasra's median patient age at 72, with 49% women.

In 2024, Dr. Jasra wrote 533 Medicare Part D claims for 64 patients. 73% of them were for generic drugs. CMS names the drug for 305 of them, across 12 drugs with 11 or more claims each, at $1,577,635 in total drug cost. In 2023, CMS named 345 claims across 16 drugs.

Dr. Jasra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jasra as offering telehealth.

Dmand AI links 13 papers to Dr. Jasra, published from 2015 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor and Breast Neoplasms. Dr. Jasra has published most often in Leuk Lymphoma. Dr. Jasra's most frequent co-authors are Ira J. Braunschweig, MD, Mendel Goldfinger, MD and Murali Janakiram, MD.

CMS Open Payments shows 6 general payments to Dr. Jasra from 6 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 85% of the total. Abbvie Inc. paid the most, $25.